The advent of artificial intelligence (AI) -- once discussed in concept but with few practical applications -- is now a reality in practically every aspect of today's world. Name an industry, and you can be sure that AI applications play a part in its operations. The use of AI is one of the fastest-growing trends in marketing today. But from what I've seen as the president of a digital marketing agency that works in the health care and wellness sector, AI is having the biggest impact in health care marketing. The proof is in the dollars: The national AI health care market is expected to reach $6.6 billion by 2021.
VivaLNK, a connected healthcare technology vendor, has introduced its Internet of Things-enabled medical wearable Sensor Platform, which comes with a range of sensors, edge computing technologies and an "Internet of Health Things" data cloud. This platform captures human vitals and biometrics, and delivers data from the patient to edge computing devices, as well as to the cloud, for application integration and analysis. Available through the VivaLNK Developer Program, the Sensor Platform enables IoT technology partners to capture streams of patient data such as heart and respiratory rates, temperature, ECG rhythms, activity and more. Partners such as Vitalic Medical, a digital health vendor specialising in the early detection of patient health deterioration and potential falls, is developing a bedside monitoring system using the platform. "Our growing aging patient population, rising complex health conditions and increasing staff workloads make it challenging for medical professionals to detect early signs of patient deterioration and prevent falls," Sue Dafnias, CEO of Vitalic Medical, said.
Voice-powered virtual assistants have huge potential for improving and expanding clinical trials, and tech companies are moving quickly to develop artificial intelligence-based software that can support and also protect the most private conversations between patients and clinicians. Katherine Vandebelt has already started scribbling down ideas about how voice assistants could work in a clinical trial environment. As Oracle's global head of clinical innovation, and former clinical innovation leader at Eli Lilly and Company, Vandebelt believes that the clinical trial experience can change with the introduction of virtual assistants into the drug research ecosystem. In April, Amazon's Alexa app became compliant with the US government's Health Insurance Portability and Accountability Act (HIPAA), and similar virtual assistants are likely to follow. Here are five changes she sees coming.
Voice-powered technologies such as Siri, Alexa, Google Assistant, and Cortana, are changing the way people shop, drive cars, and manage their homes. Studies have suggested that, by 2020, 50% of all searches will be conducted by voice and smart speakers are expected to reach 55% of U.S. households by 2022. It is no different for physicians. In a nationwide survey of pediatricians conducted by Boston Children's Hospital (not yet published), 62% of respondents said they have used voice-assistant technology, and one-third own, and use, at least one "smart speaker." Simple voice-dictation software such as Dragon that is used to capture clinical notes in electronic medical records is now fairly common in clinical settings.
A nurse avatar named "Molly" who regularly talks with patients about their symptoms and medical needs. Voice-recognition software that helps physicians document clinical encounters. A prescription drug-monitoring platform that can detect patients' opioid misuse. Systems that analyze millions of medical images to help physicians diagnose and predict diseases. Robots that extend the reach of surgeons.